Outpatient substance abuse treatment and HIV prevention: An update

Journal of Substance Abuse Treatment

Volumn 30, Issue 1, 2006, Pages 39-47

  Pollack, Harold A ^a   D'Aunno, Thomas ^b   Lamar, Barbara ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b INSEAD   (France)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

HIV testing and counseling; Outpatient substance abuse treatment; Outreach; Prevention

Indexed keywords

ARTICLE; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; NONHUMAN; OUTPATIENT; PATIENT COUNSELING; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

AMBULATORY CARE; COMMUNITY-INSTITUTIONAL RELATIONS; COUNSELING; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS;

EID: 29244461728     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2005.09.002     Document Type: Article

References (56)

1. T.A. Adams, and S.G. Heeringa Outpatient Substance Abuse Treatment System Surveys (OSATSS): Technical documentation for OSATSS-5, 1999-2000 2001 Institute for Social Research, Survey Design and Analysis Unit, University of Michigan Ann Arbor
2. A. Avins, C. Lindan, W. Woods, E. Hudes, J. Boscarino, and J. Kay Changes in HIV-related behaviors among heterosexual alcoholics following addiction treatment Drug and Alcohol Dependence 44 1997 47 55
3. J. Ball, W. Lange, C. Myers, and S. Friedman Reducing the risk of AIDS through methadone maintenance treatment Journal of Health and Social 1988 214 226
4. J.C. Ball, and A. Ross The effectiveness of methadone maintenance treatment: Patients, programs, services, and outcome 1991 Springer-Verlag New York
5. P. Barnett The cost-effectiveness of methadone maintenance as a health care intervention Addiction 94 1999 479 488
6. H. Batten, J. Prottas, C. Horgan, L. Simon, M. Larson, and E. Elliot Drug Services Research Survey, final report: Phase II 1992 Institute for Health Policy. Brandeis University Waltham, MA
7. CDC Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease Morbidity and Mortality Weekly Report 47 1998 1 39
8. CDC Drug-associated HIV transmission continues in the United States 2002 Centers for Disease Control and Prevention Atlanta, GA
9. CDC Basic statistics 2003 National Center for HIV, STD and TB Prevention Divisions of HIV/AIDS Prevention Atlanta, GA
10. CDC Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society Morbidity and Mortality Weekly Report 52 2003 1 24
11. K. Choi, and T. Coates Prevention of HIV infection AIDS 8 1994 1371 1389
12. S. Coyle, R. Needle, and J. Normand Outreach-based HIV prevention for injection drug users: A review of published outcome data Public Health Reports 113 1998 4 18
13. R. Coutinho HIV and hepatitis C among injecting drug users: Success in preventing HIV has not been mirrored for hepatitis C British Medical Journal 317 1998 424 425
14. N. Crofts, J. Hopper, R. Milner, A. Breschkin, D. Bowden, and S. Locarnini Blood-borne virus infections among Australian injecting drug users: Implications for spread of HIV European Journal of Epidemiology 10 1994 687 694
15. N. Crofts, L. Nigro, K. Oman, E. Stevenson, and J. Sherman Methadone maintenance and hepatitis C virus infection among injecting drug users Addiction 92 1997 999 1005
16. T. D'Aunno, N. Folz-Murphy, and X. Lin Changes in methadone treatment practices: Results from a panel study, 1988-1995 American Journal of Drug and Alcohol Abuse 25 1999 681 699
17. T. D'Aunno, and H.A. Pollack Changes in methadone treatment practices: Results from a national panel study, 1988-2000 Journal of the American Medical Association 288 2002 850 856
18. T. D'Aunno, and T. Vaughn Variations in methadone treatment practices: Results from a national study Journal of the American Medical Association 267 1992 253 258
19. T. D'Aunno, T. Vaughn, and P. McElroy An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units Journal of Health and Social Behavior 40 1999 175 192
20. D. Des Jarlais, H. Hagan, S. Friedman, P. Friedmann, D. Goldberg, and M. Frisher Maintaining low HIV prevalence in populations of injecting drug users Journal of the American Medical Association 274 1995 1226 1231
21. P. Diggle, K. Liang, and S. Zeger Analysis of longitudinal data 1994 Oxford University Press Oxford, UK
22. M. Farrell Drug prevention: A review of the legislation, regulation and delivery of methadone in 12 member states of the European Union 1995 National Addiction Center London, England
23. R. Garfein, M. Doherty, E. Monterroso, D. Thomas, K. Nelson, and D. Vlahov Prevalence and incidence of hepatitis C virus infection among young injection drug users Journal of Acquired immune Deficiency Syndromes and Human Retrovirology 18 1998 S11 S19
24. E. Gottheil, A. Lundy, S. Weinstein, and R. Sterling Does intensive outpatient cocaine treatment reduce AIDS risky behaviors? Journal of Addictive Diseases 17 1998 61 69
25. R. Groves, P.P. Biemer, L. Lyberg, J. Massey, W. Nicholls, and J. Waksberg Telephone survey methodology 1988 Wiley New York
26. T.M. Hammett, J.L. Gaiter, and C. Crawford Reaching seriously at-risk populations: Health interventions in criminal justice settings Health Education and Behavior 25 1998 99 120
27. S.G. Heeringa Outpatient drug abuse treatment studies: Technical documentation 1996 Institute for Social Research, University of Michigan Ann Arbor
28. R. Heimer, E. Kaplan, K. Khoshnood, B. Jariwala, and E. Cadman Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut American Journal of Medicine 95 1993 214 220
29. D. Holtgrave, N. Qualls, and J. Graham Economic evaluation of HIV prevention programs Annual Review of Public Health 17 1996 467 488
30. D. Holtgrave, W. Reiser, and W. Di Franciesco The evaluation of HIV counseling-and-testing services. Making the most of limited resources AIDS Education and Prevention 9 1997 105 118
31. D.R. Holtgrave Handbook of HIV prevention policy analysis 1998 Plenum New York
32. D.R. Holtgrave, and J.A. Kelly Preventing HIV/AIDS among high-risk urban women: The cost-effectiveness of a behavioral group intervention American Journal of Public Health 86 1996 1442 1445
33. IOM Preventing HIV transmission: The role of sterile needles and bleach 1995 Institute of Medicine, National Academy Press Washington, DC
34. IOM No time to lose: Making the most of HIV prevention 2000 National Academy Press Washington, DC
35. J.G. Kahn The cost-effectiveness of HIV prevention targeting: How much more bang for the buck American Journal of Public Health 86 1996 1709 1712
36. E.H. Kaplan, and H.A. Pollack Allocating HIV prevention resources Socio-Economic Planning Sciences 32 1998 257 263
37. M. Langendam, G. van Brussel, R. Coutinho, and E. van Ameijden Methadone maintenance and cessation of injecting drug use: Results from the Amsterdam Cohort Study Addiction 95 2000 591 600
38. Lemak C. (1998). Managed care and outpatient substance abuse treatment: A study of organizational response to external environments. Doctoral dissertation. Ann Arbor, MI: University of Michigan.
39. R. Little, and D. Rubin Statistical analysis with missing data 2002 Wiley-Interscience New York
40. D. Metzger, and H. Navaline HIV prevention among injection drug users: The need for integrated models Journal of Urban Health 80 2003 iii59 iii66
41. D. Metzger, and H. Navaline Human immunodeficiency virus prevention and the potential of drug abuse treatment Clinical Infectious Diseases 37 2003 S451 S456
42. D. Metzger, H. Navaline, and G.E. Woody Drug abuse treatment as AIDS prevention Public Health Reports 113 1998 97 106
43. D. Metzger, G. Woody, A. McLellan, C. O'Brien, P. Druley, and H. Navaline Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 6 1993 1049 1056
44. R.H. Needle, S. Coyle, J. Normand, E. Lambert, and H. Cesar HIV prevention with drug-using populations-Current status and future prospects: Introduction and overview Public Health Reports 113 1998 4 18
45. H.A. Pollack Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users Medical Decision Making 21 2001 357 367
46. H.A. Pollack Methadone treatment as HIV prevention: Cost-effectiveness analysis E.H. Kaplan R. Brookmeyer Quantitative evaluation of HIV prevention programs 2002 Yale University Press New Haven, CT 118 143
47. H.A. Pollack The challenge and future of HIV prevention Journal of Health Politics, Policy, and Law 27 2002 111 121
48. H.A. Pollack, and R. Heimer The impact and cost-effectiveness of methadone maintenance treatment in preventing HIV and hepatitis C L. Wiessing Impact and costs of hepatitis C in injecting drug users in the European Union 2004 European Monitoring Centre for Drugs and Drug Addiction Lisbon 345 370
49. M. Rahman, T. Fukui, and A. Asai Cost-effectiveness analysis of partner notification program for human immunodeficiency virus infection in Japan Journal of Epidemiology 8 1998 123 128
50. C. Reback, S. Larkins, and S. Shoptaw Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment AIDS and Behavior 8 2004 87 98
51. S. Shoptaw, D. Frosch, R. Rawson, and W. Ling Cocaine abuse counseling as HIV prevention AIDS Education and Prevention 9 1997 511 520
52. A. Somlai, J. Kelly, T. McAuliffe, K. Ksobiech, and K. Hackl Predictors of HIV sexual risk behaviors in a community sample of injection drug-using men and women AIDS and Behavior 7 2003 383 393
53. P. van Empelen, G. Kok, N. van Kesteren, B. van den Borne, A. Bos, and H. Schaalma Effective methods to change sex-risk among drug users: A review of psychosocial interventions Social Science and Medicine 57 2003 1593 1608
54. Vaughn TE. (1993). Methadone treatment practices and outcomes associated with them: An application of institutional theory [dissertation]. Ann Arbor: University of Michigan.
55. J. Wheeler, and T. Nahra Private and public ownership in outpatient substance abuse treatment: Do we have a two-tiered system? Administration and Policy in Mental Health 27 2000 197 209
56. G.S. Zaric, M.L. Brandeau, and P.G. Barnett Methadone maintenance and HIV prevention: A cost-effectiveness analysis American Journal of Public Health 90 2000 1100 1111